Floatz logo

SODIUM P-AMINOHIPPURATE

Diabetes Complications

University of Colorado, DenverSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Diabetes Complications cohort.

Asset / SponsorPhaseRating
Exenatide
University of California, Davis
Phase 2CCC
Omnipaque
University of Colorado, Denver
Phase 1/2CCC
Primepro™/ Primemsk™
Thomas Advanced Medical LLC
Phase 1/2CCC
Gfb-024
Goldfinch Bio, Inc.
Phase 1CC

Same molecule, other indications

SODIUM P-AMINOHIPPURATE is also rated in:

diabetic kidney diseaseDormant
CCC
Indicative ·
52 / 100
View asset →
type 2 diabetes mellitusDormant
CCC
Indicative ·
50 / 100
View asset →
morbid obesityDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →